Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Ariceum Therapeutics Expands Pipeline with Acquisition of Theragnostics
Ariceum Therapeutics, a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of […]
Antengene Announces Antibody-Drug Conjugate Granted Orphan Drug Designations by the FDA for the Treatment of Gastric and Pancreatic Cancers
Antengene Corporation, a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing […]
Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
Ratio Therapeutics, a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class […]
FLASH Proton Therapy Clinical Trial Begins on Cancers Involving Bones in the Chest
Treatment of the first participant in a clinical trial of FLASH proton therapy for cancers […]
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Flare Therapeutics, a biotechnology company targeting transcription factors to discover precision medicines for cancer and […]
BiPER Therapeutics Raises €1.25 Million in Seed Funding to Develop First-in-class Small Molecules to Treat Gastrointestinal Cancers
BiPER Therapeutics, a preclinical biotechnology company developing first-in-class drug candidates targeting BiP protein to treat […]
Treadwell Therapeutics Announces the Appointment of Roger Sidhu, M.D., as Chief Medical Officer
Treadwell Therapeutics, a clinical-stage, global biotechnology company developing novel, first-in-class therapeutics for highly aggressive cancers, […]
RefleXion Receives FDA Clearance for Biology-Guided Radiotherapy Treatment for Early and Late-stage Cancers
RefleXion Medical, a therapeutic oncology company, today announced the US Food and Drug Administration (FDA) […]
Qurient Announces Dosing of First Patient in Clinical Study for the Treatment of Patients with Solid Tumors
Qurient, a clinical-stage biotech company based in Korea, has announced that the first patient has […]
CNS Pharmaceuticals Appoints Faith L. Charles, JD as Chair of the Board of Directors
CNS Pharmaceuticals, a biopharmaceutical company specializing in the development of novel treatments for primary and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more